Extended-Duration Low-Dose Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism
Conditions: Deep Vein Thrombosis; Pulmonary Embolism; Venous Thromboembolism Interventions: Drug: Apixaban 2.5 MG; Drug: Placebo oral tablet Sponsor: Brigham and Women's Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials